Aeon Global Health Corp. announced restatement of earnings results for the quarter ended September 30, 2018. In the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2018, the Company erroneously classified the Senior Convertible Notes on its balance sheet as a current liability and conducted a valuation of the conversion feature of such Senior Convertible Notes based on the prior maturity date of such notes. Due to the error in classification on the balance sheet, the Company overstated its working capital deficit for the quarter ended September 30, 2018. In addition, due to such error, the valuation of such notes was not accurate and the “other expense” as reported on the consolidated statement of operations in the original Form 10-Q was underreported by $185,851. Although, such amount is a non-cash expense, the net loss and net loss available to common shareholders previously reported by the Company was incorrect and will be increased. Due to the increase in other expense, net loss for the quarter ended September 30, 2018 will increase from $223,372 to $409,223 and net loss available to common shareholders for such period will increase from $309,087 to $494,938; and the Company’s basic and diluted loss per common share will increase from $0.04 per share to $0.07 per share.